Albany College of Pharmacy and Health Sciences to host nanomedicine symposium
"Advances in nanomedicine are happening so quickly that it can be difficult to stay current with the latest developments," Pharmaceutical Research Institute Executive Director Shaker Mousa said. "The goal of our symposium and accompanying workshop is to update participants on the state of nanomedicine today courtesy of some of the brightest minds in the field. The Capital Region's strengths in nanotechnology, biomedical research, higher education and healthcare make Albany an ideal location for such an event."
Organizations set to appear at the event include the Albany Medical Center, Rensselaer Polytechnic Institute, SUNY Polytechnic Institute, the University at Albany, Cornell University, Northeastern University, Rutgers University, SUNY Buffalo, Syracuse University, the University of Massachusetts (Amherst), Bristol Myers-Squibb, Microfluidics, Particle Sciences, the National Cancer Institute and the U.S. Consumer Product Safety Commission.
"Nanomedicine holds great promise for the next generation of drug therapy," Greg Dewey, president of ACPHS, said. "It has the potential of combining high selectivity with low toxicity to greatly improve drug efficacy. ACPHS is very pleased to be hosting this forward-looking conference of researchers and will continue to actively advance this emerging field."
A full schedule and information about how to register for the event can be found at www.pri-albany.org/nanomedicine.